Listen to CLiC Podcast Episode #3: Dr. Versha Banerji reviews the Phase III Alliance A041202 results on ibrutinib alone or with rituximab as front-line therapy in older CLL patients (11:20)

CLiC Podcast Episode #3: Dr. Versha Banerji reviews the Phase III Alliance A041202 results on ibrutinib alone or with rituximab as front-line therapy in older CLL patients (11:20)